CareDx Q2 Revenues Up 51 Percent | GenomeWeb

NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Wednesday that its second quarter revenues rose 51 percent year over year thanks to record volumes of its AlloMap non-invasive blood test for heart transplant patients.

For the three months ended June 30, the firm reported total revenues of $10.7 million, up from $7.1 million a year ago, and narrowly beating the consensus Wall Street estimate for revenues of $10.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

In Nature this week: genetic history of HIV in the US, and more.